From Surf Wiki (app.surf) — the open knowledge base
Doxefazepam
Chemical compound
Chemical compound
| elimination_half-life = 3-4 hours
Doxefazepam (marketed under brand name Doxans) is a benzodiazepine medication. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is used therapeutically as a hypnotic. According to Babbini and colleagues in 1975, this derivative of flurazepam was between 2 and 4 times more potent than the latter while at the same time being half as toxic in laboratory animals.
It was patented in 1972 and came into medical use in 1984.
Side effects
Section 5.5 of the article Doxefazepam in volume 66 of the World Health Organization's (WHO) and International Agency for Research on Cancer's (IARC) IARC Monographs On The Evaluation Of Carcinogenic Risks To Humans, an article describing the carcinogenic/toxic effects of doxefazepam on humans and experimental animals, states that there is "inadequate evidence in humans for the carcinogenicity of doxefazepam" and limited evidence in experimental for the carcinogenicity of doxefazepam," and concluded that the overall evaluation of the substance's carcinogenicity to humans is "not classifiable."
References
References
- "Doxefazepam". IPCS INTOX.
- (1984). "Effects of doxefazepam on normal sleep. An EEG and neuropsychological study". Neuropsychobiology.
- (August 1975). "Sedative-hypnotic properties of a new benzodiazepine in comparison with flurazepam. Pharmacological and clinical findings". Arzneimittel-Forschung.
- (2006). "Analogue-based Drug Discovery". John Wiley & Sons.
- (13–20 Feb 1996). "Doxefazepam". International Agency For Research On Cancer (IARC).
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Doxefazepam — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report